Frankfurt - Delayed Quote EUR
Intellia Therapeutics, Inc. (38I.F)
6.79
-0.71
(-9.44%)
At close: June 13 at 9:15:05 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-377,148
-348,880
-394,086
-333,287
-225,030
Investing Cash Flow
213,994
125,567
-31,347
160,309
-550,778
Financing Cash Flow
125,755
185,747
130,323
582,955
736,688
End Cash Position
148,185
202,787
240,353
535,463
125,486
Capital Expenditure
-4,007
-5,778
-13,985
-58,390
-12,756
Issuance of Capital Stock
118,865
176,899
119,795
565,789
693,570
Free Cash Flow
-381,155
-354,658
-408,071
-391,677
-237,786
12/31/2021 - 5/12/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
UP0.F Ultragenyx Pharmaceutical Inc.
33.40
+3.73%
4DN.MU Denali Therapeutics Inc.
12.91
-2.23%
2L9.F Blueprint Medicines Corporation
109.00
-0.91%
26CA.F ImmunityBio, Inc.
2.6460
-3.18%
2LB.F Iovance Biotherapeutics, Inc.
1.9322
+1.19%
PALI Palisade Bio, Inc.
0.6401
-7.23%
VNDA Vanda Pharmaceuticals Inc.
4.5100
-2.59%
GOVX GeoVax Labs, Inc.
1.0300
-9.65%
TVGN Tevogen Bio Holdings Inc.
1.2400
-2.36%
FBIO Fortress Biotech, Inc.
1.8500
-5.61%